logo

 

MIRA INFORM REPORT

 

 

Report Date :

21.04.2011

 

IDENTIFICATION DETAILS

 

Name :

LABORATÓRIO SANOBIOL LTDA

 

 

Registered Office :

Rua Olinda, 184 - Capela Do Socorro

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2009

 

 

Date of Incorporation :

18.06.1974

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Manufacture of Pharmaceuticals and Disposable Hospital Material.

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

US$ 1.000,000,00

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2010

 

Country Name

Previous Rating

(30.09.2010)

Current Rating

(31.12.2010)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Company name

 

LABORATÓRIO SANOBIOL LTDA

 

 

Company ADDRESSES

 

MAIN ADDRESS:

RUA OLINDA, 184 - CAPELA DO SOCORRO

ZIP CODE/CITY:

04761-020 - SĂO PAULO/SP

 

 

PHONE:

11 5523-6199

FAX:

11 5686-8979

E-MAIL:

tais@sanobiol.com.br

WEB SITE:

www.sanobiol.com.br

 

BRANCHES:

 

 

 

ADDRESS:

AVENIDA DAS QUARESMEIRAS - S/Nş. - DISTRITO INDUSTRIAL

ZIP CODE/CITY:

37550-000 POUSO ALEGRE/MG

PHONE:

35 3449-2600

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

MANUFACTURE OF PHARMACEUTICALS AND DISPOSABLE HOSPITAL MATERIAL.

 

LEGAL FORM:

LIMITED LIABILITY COMPANY

 

 

INCORPORATION DATE:

18/06/1974

REGISTER DATE:

18/06/1974

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER (CNPJ):

21.561.931/0001-39

STATE REGISTER:

109.183.474.113

 

 

SHARE CAPITAL:

R$ 9.000.000,00

 

BOARD OF DIRECTORS:

 

 

 

HENRIQUE MONTANARI NAVAS

ADMINISTRATIVE DIRECTOR

 

 

AUTHORIZED USE OF SIGNATURE

THE DIRECTOR IS AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

 

SHAREHOLDERS / PARTNERS:

 

 

 

MANEESH PHARMACEUTICALS PRIVATE LIMITED

R$ 8.999.990,00

VINAY RAMAKANT SAPTE

R$        10,00

 

AFFILIATES / SUBSIDIARIES:

 

MAX SOLUTION ASSISTĘNCIA TÉCNICA EM EQUIPAMENTOS INDUSTRIAIS S/C LTDA

FRANAV PARTICIPAÇŐES S.A.

PHOEBEL ASSISTĘNCIA TÉCNICA EM EQUIPAMENTOS INDUSTRIAIS LTDA

LASA INDÚSTRIA FARMACĘUTICA LTDA

ÁUREA IMPORTADORA E EXPORTADORA DE PRODUTOS MÉDICOS LTDA EPP

 

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON JUNE 18, 1974 AS LABORATÓRIO SANOBIOL S/A. TO BE ENGAGED IN THE SAID LINE OF BUSINESS. LATER IT ADOPTED THE ABOVE-MENTIONED NAME.

 

THE COMPANY OPERATES WITH THE TRADE NAME "SANOBIOL".

 

THE PARTNERS / DIRECTOR:

 

MANEESH PHARMACEUTICALS PRIVATE LIMITED: HEADQUARTERED AT 23-24 KALPATARU COURT, DR. CHOITRAM GIDWANI MARG, CHE MBUR, MUMBAI, 400 074, INDIA;

 

VINAY RAMAKANT SAPTE: INDIAN, HOLDER OF DOCUMENT # CPF 744.047.841-04, RESIDENTIAL ADDRESS AT 61, TOWER A KALPATARU RESIDENCY, KAMANI MARG, OPP. CINE PLANET, SION, MUMBAI - 400022, MAHARASHTRA STATE, INDIA;

 

HENRIQUE MONTANARI NAVAS: BRAZILIAN, HOLDER OF DOCUMENTS # CPF  135.192.368-45, # RG 93771770 SP, RESIDENTIAL ADDRESS AT RUA COMENDADOR ELIAS ZARZUR, 269, SANTO AMARO, ZIP CODE 04736-000, SĂO PAULO/SP, REPRESENTING MANEESH PHARMACEUTICALS PRIVATE LIMITED AND VINAY RAMAKANT SAPTE.

 

FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY IS SO FAR NOT KNOWN.

 

PUBLIC INFORMATION:

 

LAWSUITS:

 

 

 

DATE:

COURT OF LAW:

 

1

FEDERAL LAWSUIT

18/09/08

3Ş VARA DE SĂO PAULO/SP - FEDERAL

 

 

 

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2009.

(FIGURES ARE IN REAIS).

ASSETS

 

 

 

CURRENT:

31/12/2009

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS

2.214.960,68

 

 

CLIENTS

8.295.176,72

 

 

INVENTORY

3.010.280,98

 

 

CREDITS

872.849,26

 

 

RECOVERABLE TAXES

899.149,19

 

 

INVESTMENTS

1.155.715,63

 

 

ADVANCES

4.285.769,02

 

 

PRE PAID EXPENSES

712.554,81

 

 

 

----------------

 

 

TOTAL CURRENT ASSETS

21.446.456,29

 

 

 

FIXED ASSETS:

 

 

 

 

 

 

 

INVESTMENTS

99.013,94

 

 

FIXED ASSETS

17.454.275,89

 

 

 

----------------

 

 

TOTAL FIXED ASSETS

17.553.289,83

 

 

 

================

 

 

TOTAL ASSETS

38.999.746,12

 

 

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2009

 

 

 

 

 

 

LOANS AND FINANCING

2.574.346,67

 

 

SUPPLIERS

5.689.223,04

 

 

FOREIGN SUPPLIERS

440.626,58

 

 

TRIBUTARY OBLIGATIONS

728.524,33

 

 

SOCIAL OBLIGATIONS

1.339.808,03

 

 

COMMISSIONS DUE

752.998,69

 

 

FREIGHTS PAYABLE

771.410,62

 

 

OTHER

1.299.073,91

 

 

 

----------------

 

 

TOTAL CURRENT LIABILITIES

13.596.011,87

 

 

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

5.836.032,97

 

 

 

----------------

 

 

TOTAL LONG TERM LIABILITIES

5.836.032,97

 

 

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

10.080.000,00

 

 

CAPITAL RESERVES

472.000,00

 

 

ACCRUED PROFIT (LOSS)

5.610.049,10

 

 

PROFIT (LOSS) OF PERIOD

3.405.652,18

 

 

 

----------------

 

 

TOTAL NET EQUITY

19.567.701,28

 

 

 

================

 

 

TOTAL LIABILITIES

38.999.746,12

 

 

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2009.

(FIGURES ARE IN REAIS).

 

 

31/12/2009

 

 

 

 

 

 

GROSS SALES

53.406.126,69

 

 

(-) TAXES ON SALES

5.891.960,59

 

 

 

----------------

 

 

NET SALES

47.514.166,10

 

 

(-) COST OF SOLD GOODS

30.355.840,60

 

 

 

----------------

 

 

GROSS PROFIT

17.158.325,50

 

 

OPERATING REVENUE (EXPENSE)

-10.558.313,15

 

 

FINANCIAL REVENUE (EXPENSE)

-1.545.541,63

 

 

 

----------------

 

 

OPERATIONAL PROFIT (LOSS)

5.054.470,72

 

 

NON-OPERATING RESULT

69.230,20

 

 

CONTRIBUTION/INCOME TAX

-1.718.048,74

 

 

 

----------------

 

 

NET PROFIT (LOSS)

3.405.652,18

 

 

 

MONTHLY SALES

 

  2010

 

 

 

---------------------

 

 

JANUARY

R$ 6.601.328,10

 

 

FEBRUARY

R$ 6.176.997,29

 

 

MARCH

R$ 7.506.717,28

 

 

APRIL

R$ 7.277.937,06

 

 

MAY

R$ 6.531.587,50

 

 

JUNE

R$ 5.428.249,03

 

 

JULY

R$ 4.370.022,62

 

 

AUGUST

R$ 4.468.455,20

 

 

SEPTEMBER

R$ 4.142.944,16

 

 

OCTOBER

R$ 3.575.757,84

 

 

NOVEMBER

R$ 3.587.327,64

 

 

DECEMBER

R$ 3.544.576,49

 

 

TOTAL

R$ 63.211.900,21

 

 

 

RATIOS:

31/12/2009

 

 

 

QUICK RATIO

1,36

 

 

 

 

 

CURRENT RATIO

1,58

 

 

 

 

 

ACCOUNTS RECEIVABLE TURNOVER

5,73

TIMES

 

 

 

 

DAYS' SALES IN RECEIVABLES

62,85

DAYS

 

 

 

 

INVENTORY TURNOVER

10,08

TIMES

 

 

 

 

ACCOUNTS PAYABLE PERIOD

67,47

DAYS

 

 

 

 

RETURN ON ASSETS

1,22

TIMES

 

 

 

 

SALES TURNOVER ON NET EQUITY

2,43

TIMES

 

 

 

 

NET WORTH TIE-UP

,89

 

 

 

 

 

INDEBTEDNESS

,99

 

 

 

 

 

EQUITY RATIO

50,17

%

 

 

 

 

WORKING CAPITAL RATIO

57,74

%

 

 

 

 

GENERAL SOLVENCY

2,01

 

 

 

 

 

RETURN ON NET EQUITY

17,40

%

 

 

 

 

RETURN ON SALES (PROFIT MARGIN)

7,17

%

 

 

 

 

GROSS PROFIT MARGIN

36,11

%

 

 

 

 

OPERATIONAL RESULT

10,64

%

 

 

 

 

SALES TURNOVER ON LIABILITIES

3,49

TIMES

 

 

 

 

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 1,57

 - OFFICIAL RATE ON 19/04/2011

US$ 1,00 = R$ 1,74

 - OFFICIAL RATE ON 31/12/2009

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A NORMAL FINANCIAL STANDING. IT SHOWS GOOD LIQUIDITY RATIOS AND POSITIVE WORKING CAPITAL AMOUNT, AS WELL AS ACCEPTABLE LEVEL OF INDEBTEDNESS. IT ALSO SHOWS GOOD SALES AND POSITIVE RESULT.

 

REMARKS:

 

THE SHARE CAPITAL SHOWED IN THE BALANCE SHEET IS DIFFERENT FROM THE REGISTERED SHARE CAPITAL. THE COMPANY STATED THAT THEY HAVE NOT REGISTERED THE NEW SHARE CAPITAL YET. NO FURTHER DETAILS WAS DISCLOSED.

 

REAL ESTATE:

 

NOT AVAILABLE.

 

VEHICLES:

 

 NOT AVAILABLE.

 

MACHINES:

 

   NOT AVAILABLE.

 

 

INSURANCE

 

NOT AVAILABLE.

 

 

BANKING REFERENCES

 

 

NOT AVAILABLE.

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

MANUFACTURE OF PHARMACEUTICALS AND DISPOSABLE HOSPITAL MATERIAL.

 

IMPORT AND EXPORT:

 

IMPORTS FROM:

NOT AVAILABLE.

 

EXPORTS TO:

NOT AVAILABLE.

 

MAIN CLIENTS:

 

NOT AVAILABLE.

 

STAFF:

 

THE COMPANY HAS: 200 EMPLOYEES

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT WAS ESTABLISHED IN 1974. SO FAR IT HAS A CLEAR TRADE HISTORY AND NORMAL PAYMENT BEHAVIOUR.

 

THE COMPANY HAS TRADE RELATIONS WITH SOME LOCAL SUPPLIERS BUT UP TO DATE ONLY SMALL PAYMENTS WERE REPORTED AND THE SUBJECT IS NOT SAID TO BE USER OF TRADE CREDIT FACILITIES.

 

THE LAWSUIT REPORTED IS NOT RELATED WITH TRADE DEBT. IT IS RELATED TO TAX DEBT THAT FOR ANY REASON THE COMPANY HAS NOT YET PAID. NEVERTHELESS WE POINT OUT THAT THE SAID LAWSUIT DOES NOT AFFECT THE COMPANY'S TRADE REPUTATION.

 

MAIN SUPPLIERS:

 

NOT AVAILABLE.

 

PAYMENT HISTORY:

 

11 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT: R$ 80.150,00

 

AMOUNT OF INVOICES PAID: 51

TOTAL OF PROMPT PAYMENTS: 100%

HIGHEST INVOICE: R$ 5.500,00

HIGHEST CREDIT: R$ 5.500,00

 

OUTSTANDING INVOICES DUE WITHIN THE NEXT 30 DAYS:

 

---------------------------

SUPPLIERS:

INVOICES:

TOTAL AMOUNT:

DUE WITHIN 30 DAYS

1

1

R$ 1.606,89

 

 

FINAL OPINION

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR SEVERAL YEARS. UP TO DATE IT HAS A NORMAL FINANCIAL STANDING, A CLEAR TRADE HISTORY AND NORMAL PAYMENT BEHAVIOR.

 

BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH.

 

A CREDIT LIMIT OF US$ 1.000.000,00 MAY BE CONSIDERED.

 

 

 



FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.

UK Pound

1

Rs.

Euro

1

Rs.

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.